Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000729054 | SCV000856690 | uncertain significance | not provided | 2017-09-19 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002533097 | SCV003445629 | uncertain significance | Familial aplasia of the vermis; Meckel-Gruber syndrome | 2021-09-24 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine with cysteine at codon 533 of the MKS1 protein (p.Arg533Cys). The arginine residue is moderately conserved and there is a large physicochemical difference between arginine and cysteine. This variant is present in population databases (rs745946583, ExAC 0.03%), including at least one homozygous and/or hemizygous individual. This variant has not been reported in the literature in individuals affected with MKS1-related conditions. ClinVar contains an entry for this variant (Variation ID: 593886). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV005027902 | SCV005649597 | uncertain significance | Bardet-Biedl syndrome 13; Meckel syndrome, type 1; Joubert syndrome 28 | 2024-03-01 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004535817 | SCV004116359 | uncertain significance | MKS1-related disorder | 2024-06-03 | no assertion criteria provided | clinical testing | The MKS1 c.1597C>T variant is predicted to result in the amino acid substitution p.Arg533Cys. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.13% of alleles in individuals of Ashkenazi Jewish descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |